PCSK9
OrganizationHeard in 2 episodes across 2 shows since Oct 2026
PCSK9 is a gene encoding a protein that regulates low-density lipoprotein cholesterol receptors and is a genetically validated target for cholesterol-lowering therapies.
Episodes
2
across 2 shows
First heard
Oct 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
1
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
| Nov 2026 | 1 |
Email alert
Email me when PCSK9 comes up on a podcast
One email a week at most, with the new episodes that mention PCSK9. Free, no account needed, unsubscribe in one click.
What experts have said about PCSK9
1 statement · 1 positive
People with faulty PCSK9 genes have 85% to 90% lower heart-disease risk
“they have a 85 to 90% risk reduction of heart disease”
Open the episode · Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]Listen at 52:37
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring PCSK9, newest first
